Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
Bookmark and Share

7E F Stange

 

Summary for 2004 [at-glance overview of E F Stange work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author E F Stange. According to available data, in 2004 E F Stange published at least 7 articles. This work was completed in collaboration with several authors including Herrlinger, K and Fellermann, K. Many other authors have collaborated with E F Stange as well. There is no information about the funding or the grants awarded to support this work.

E F Stange has rank 40 when compared to all other authors using the keyword Crohn Disease. Analysis of the article abstracts and the titles suggests that E F Stange professional interests are focused around "patients nod2 mutations", "mutations crohn disease" and "inflammatory bowel diseases". These might also be referred to as "crohn disease", "nod2 mutations" or "hd-5 hd-6". Statistical analysis shows that E F Stange's writing is likely to contains terms "disease", "nod2", "crohn", "expression", "mutations" and "mucosal".

Unfortunately, there is not enough information to establish E F Stange affiliation. Luckily, several email addresses are on file.

ENFRESRUAccurate information, makes sense to meInaccurate information, needs improvementmake correctionleave commentask question

Images [images we found on the Internet for E F Stange]

    loading...

    Do you know E F Stange who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to E F Stange]

Year 2004 Charts [E F Stange frequent coauthors and the most common unique vocabulary terms for the selected year]

  • E F Stange - Coauthors & Social Network in 2004E F Stange - Unique Vocabulary, Keywords and Interests in 2004

Historical Performance Charts [graphical overview of E F Stange publication and funding history for the range of years]

  • E F Stange - Publications and Funding History in 2004

Emails (2) [email addresses extracted from E F Stange affiliations]

hidden to prevent spam, click here to reveal

Other [context-specific ads]

Affiliations (6) [condensed summary of the E F Stange affiliations, the leading number and the color conveys importance]

  • 1Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany.
    1Abteilung Innere Medizin 1, Zentrum für Innere Medizin, Robert-Bosch-Krankenhaus, Stuttgart.
    1Medizinische Klinik I mit Schwerpunkt Gastroenterologie/Infektiologie/Rheumatologie, Charité, Universitätsmedizin Berlin.
    1Robert-Bosch-Krankenhaus, Zentrum für Innere Medizin, Stuttgart.
    1Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany.
    1Abteilung Innere Medizin I, Robert-Bosch-Krankenhaus, Stuttgart.

Key Opinion Leader In [E F Stange is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

  • 40Crohn Disease | 60Colitis, Ulcerative | 76Remission Induction

Keywords (32) [keywords assigned to E F Stange articles by PubMed, the leading number and the color conveys importance]

  • 7Humans | 4Crohn Disease | 4Adult | 3Colitis, Ulcerative | 3Female | 3Remission Induction | 2Adolescent | 2Pouchitis | 2Diagnosis, Differential | 2Inflammatory Bowel Diseases | 2Anti-Bacterial Agents | 2Recurrence | 2Controlled Clinical Trials as Topic | 2Gene Expression Regulation | 2Risk Factors | 2Immunity, Mucosal | 2Middle Aged | 2Male | 1Colon | 1Interleukin-8 | 1Intestines | 1alpha-Defensins | 1Defensins | 1Primary Prevention | 1Thionucleotides | 1Tumor Necrosis Factor-alpha | 1Immunosuppressive Agents | 1Tacrolimus | 1Nod2 Signaling Adaptor Protein | 1Azathioprine | 1RNA, Messenger | 1Magnetic Resonance Imaging

E F Stange Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; E F Stange might be a good expert witness on these terms]

  • 15disease | 14nod2 | 12crohn | 8expression | 8mutations | 8mucosal | 7defensins | 5patients | 5response | 5hd-5 | 5paneth | 5bowel | 56-thioguanine-nucleotide | 5levels | 5diminished | 4inflammatory | 4bacterial | 4diseases | 4hd-6 | 4barrier | 4ileum | 4human | 4defensin | 4pathogenesis | 3cells | 3colitis | 3tioguanine | 3lysozyme | 3intestinal | 3wild-type | 3spla2 | 3activity
  • 11crohn disease | 5nod2 mutations | 4hd-5 hd-6 | 3patients nod2 | 3inflammatory bowel | 3paneth cells | 3mutations crohn | 3bowel disease | 2mucosal barrier | 2bowel diseases | 26-thioguanine-nucleotide levels | 2may explain | 2methylated 6-thioguanine-nucleotide | 2hd-6 spla2 | 2defensin expression | 2ulcerative colitis | 2wild-type nod2 | 2mutations wild-type | 2expression may | 2card15 mutations | 2nod2 card15 | 2role defensins | 2associated diminished | 2disease associated | 2thioguanine-nucleotides predict | 2alpha-defensin expression | 2alpha defensins | 2pathogenesis chronic-inflammatory | 2predict efficacy | 2diminished mucosal | 2mutations nod2 | 2mucosal alpha-defensin
  • 3patients nod2 mutations | 3mutations crohn disease | 2inflammatory bowel diseases | 2hd-5 hd-6 spla2 | 2nod2 mutations wild-type | 2expression may explain | 2nod2 card15 mutations | 2mucosal alpha-defensin expression | 2efficacy tioguanine crohn | 2defensins pathogenesis chronic-inflammatory | 2chronic-inflammatory bowel disease | 2predict efficacy tioguanine | 2disease associated diminished | 2crohn disease associated | 2tioguanine crohn disease | 2thioguanine-nucleotides predict efficacy | 2associated diminished mucosal | 2card15 mutations crohn | 2role defensins pathogenesis | 2pathogenesis chronic-inflammatory bowel | 2diminished mucosal alpha-defensin | 1thioguanine-nucleotide levels paradigm | 1associated nod2 mutation | 1nucleotide levels patients | 1experienced bone marrow | 1based consensus conference | 1tioguanine therapy related | 1patients immunohistochemistry identified | 1results evidence based | 1protozoa giardia lamblia | 1mucosal adherent invasive | 1crohn disease especially

Reader's Comments (0) [comments posted by readers of E F Stange profile]

no comments yet

Funding (0) [selected NIH grants to E F Stange and the award amounts for recent years]

  • award information is not available

E F Stange Articles (7) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]

Science Trivia (2) [Interactive math & science trivia questions]